Mizuho Securities Cuts Price Target on Pacira Pharma (PCRX); Sights Conservatism

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Mizuho Securities Cuts Price Target on Pacira Pharma (PCRX); Sights Conservatism

Pacira Pharma (PCRX) Tops Q1 EPS by 8c; EXPAREL Sales Rose 14%

May 2, 2016 8:57 AM EDT

Pacira Pharma (NASDAQ: PCRX) reported Q1 EPS of $0.15, $0.08 better than the analyst estimate of $0.07. Revenue for the quarter came in at $65.5 million versus the consensus estimate of $67.11 million.

EXPAREL net product revenues were $63.8 million in the first quarter of 2016, compared to $56.0 million in... More

Trading Radar for 5/2: AIG (AIG), Ferrari (RACE), Loews (L), On Deck Capital (ONDK), Tenet Healthcare (THC) Report

April 29, 2016 3:24 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

Boardwalk Pipeline Partners (NYSE: BWP) - consensus EPS $0.35
Broadsoft (Nasdaq: BSFT) - consensus EPS $0.26
CEVA, Inc. (Nasdaq: CEVA) - consensus EPS $0.16
CNA Financial (NYSE: CNA) - consensus EPS $0.63
Diamond Offshore Drilling (NYSE: DO) - consensus EPS $0.27
Education Realty Trust (NYSE: EDR) -... More